Close Menu
  • Homepage
  • Local News
  • India
  • World
  • Politics
  • Sports
  • Finance
  • Entertainment
  • Business
  • Technology
  • Health
  • Lifestyle
Facebook X (Twitter) Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
Facebook X (Twitter) Instagram Pinterest
JHB NewsJHB News
  • Local
  • India
  • World
  • Politics
  • Sports
  • Finance
  • Entertainment
Let’s Fight Corruption
JHB NewsJHB News
Home»Finance»Gilead Sciences, Moderna, Tesla and more
Finance

Gilead Sciences, Moderna, Tesla and more

December 21, 2022No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Gilead Sciences, Moderna, Tesla and more
Share
Facebook Twitter LinkedIn Pinterest Email

An indication is posted in entrance of the Gilead Sciences headquarters on April 29, 2020 in Foster Metropolis, California.

Justin Sullivan | Getty Pictures

Try the businesses making the most important strikes noon:

Normal Mills — Normal Mills dropped 3.99%, regardless of reporting better-than-expected income and revenue for the final quarter. The meals producer additionally raised its full-year forecast. Larger costs partially offset elevated output prices.

Gilead Sciences — Gilead Sciences sank 1.91% after saying its Kite unit would purchase biotech firm Tmunity Therapeutics. The corporate warned the deal may scale back 2023 earnings per share by roughly 18-22 cents.

Lucid — Shares of Lucid rose greater than 3% in noon buying and selling after the electrical car maker introduced a capital increase of about $1.5 billion by a collection of inventory gross sales. The inventory closed flat.

Tesla – Shares of Tesla sank 8.05% after Evercore ISI lowered its worth goal on them, citing issues because the inventory failed to carry a key degree. The inventory has been harm this month by worries about its China operation and issues about CEO Elon Musk’s new management at Twitter.

Moderna — Shares of the drug maker rose 5.94% on Tuesday. On Monday, the inventory was upgraded by Jeffries to purchase from maintain. A promising new most cancers vaccine has renewed curiosity within the inventory, the agency stated.

QuantumScape — Shares of electrical car maker QuantumScape jumped 3% in noon buying and selling after the corporate stated it might begin delivery prototypes of its batteries to automakers. Nonetheless, the inventory closed down 1.37%.

FactSet Analysis — FactSet Analysis’s inventory slid practically 5.39% after the monetary information and analytics firm reported quarterly income of $504.8 million, lower than the $510.5 million anticipated from analysts, per StreetAccount. Nonetheless, it beat on earnings, reporting an adjusted revenue of $3.99 per share versus the $3.62 anticipated.

Steelcase — Steelcase rallied 9.6% after reporting better-than-expected third-quarter earnings and issuing an upbeat revenue forecast. Whereas the office-furniture maker’s quarterly income fell wanting estimates, its order backlog is 3% increased than it was a yr in the past.

Newmont — The gold miner climbed 4.43% as the worth of gold climbed above $1,800. Nonetheless, the inventory is down greater than 22% yr to this point, on tempo for its first annual decline since 2018.

Commerce Desk — Commerce Desk gained 5.57% after Piper Sandler initiated protection of the digital promoting firm with an obese score. “Regardless of the ‘promoting VIX’ being at all-time highs, the corporate has continued to execute and outperform the broader digital promoting panorama,” Piper stated.

Sew Repair — Shares dropped 9.09% after JPMorgan downgraded the net attire firm to underweight from impartial. The funding agency stated Sew Repair has had a “powerful yr” after 4 consecutive quarters of declines in lively shoppers, JPMorgan stated.

Loews — Shares of Loews gained 1.51% after the corporate introduced the Delaware Supreme Court docket reversed a call that had awarded former minority unitholders in its Boardwalk Pipelines subsidiary about $690 million, plus curiosity.

Arch Capital — The Bermuda-based insurance coverage firm rose 2.81%. Arch Capital introduced Monday it elevated its share repurchase authorization to $1 billion. At Sept. 30, about $596.4 million of share repurchases had been obtainable.

— CNBC’s Carmen Reinicke, Tanaya Macheel and Sarah Min contributed reporting.

Source link

Gilead Moderna Sciences Tesla
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Rising oil prices may wipe out effects of Trump’s ‘big beautiful bill’

March 10, 2026

Is Sweetgreen a Buy, Sell, or Hold in 2026?

March 10, 2026

Got a low rate? Now consider this.

March 10, 2026

Gold opens lower after oil prices spike

March 10, 2026
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Rising oil prices may wipe out effects of Trump’s ‘big beautiful bill’

March 10, 2026

Mark Butcher slams Pak’s obsession, hails Gambhir’s India after T20 World Cup win

March 10, 2026

Genesis Frontman Needs Round-the-Clock Care

March 10, 2026

Enterprise identity was built for humans — not AI agents

March 10, 2026
Popular Post

‘I switched it up’: Madhuri Dixit’s husband Dr Shriram Nene reveals he lost 18 kgs and brought body fat down to 16 percent after health scare; here’s what he did | Health News

How tennis couples like ‘Tsitsidosa’ navigate what it’s like to date a tennis player

Bengaluru man bags job in Google after long struggle. His mother reacts | Bengaluru

Subscribe to Updates

Get the latest news from JHB News about Bangalore, Worlds, Entertainment and more.

JHB News
Facebook X (Twitter) Instagram Pinterest
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
© 2026 Jhb.news - All rights reserved.

Type above and press Enter to search. Press Esc to cancel.